Protagonist Therapeutics(DE:PGF)
€75.000.00 (0.00%)
DE:PGF
Protagonist Therapeutics hedge funds
€75.00
At close:0.00 (0.00%)
Protagonist Therapeutics (PGF) Hedge Fund Trading Activity
1 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 214.0K Shares Last Quarter
Hedge Fund Holdings in PGF
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 George Soros | Soros Fund Mangment LLC | New | 100.00% | $8,734,000 | 0.10% | ||
 Ken Fisher | Fisher Asset Management LLC | New | 100.00% | $5,687,056 | <0.01% | ||
 Joseph Edelman | Perceptive Advisors LLC | Added | 31.09% | $117,946,119 | 2.10% | ||
 Stanley Druckenmiller | Duquesne Family Office LLC | Not Changed | 0.00% | $13,948,198 | 0.31% | ||
 Chuck Royce | Royce & Associates LLC | Not Changed | 0.00% | $1,483,819 | 0.02% | ||
 Andrew J.M. Spokes | Farallon Capital Management, L.L.C. | Reduced | -0.84% | $536,617,484 | 2.59% | ||
| Michael Rockefeller | Woodline Partners LP | Reduced | -2.05% | $123,042,146 | 0.48% | ||
 Richard Driehaus | Driehaus Capital Management LLC | Reduced | -3.57% | $96,001,507 | 0.65% | ||
 John Hussman | Hussman Strategic Advisors Inc | Reduced | -40.00% | $1,100,484 | 0.27% | ||
 Charles Davidson | Wexford Capital LP | Sold Out | -100.00% | $82,186 | 0.00% |
FAQ
Which hedge funds hold Protagonist Therapeutics?
The hedge funds that hold the most shares in Protagonist Therapeutics are Andrew J.M. Spokes, Michael Rockefeller and Joseph Edelman.
Are hedge funds buying or selling DE:PGF?
In the last quarter hedge funds have Decreased their holdings in Protagonist Therapeutics by 214.0K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Protagonist Therapeutics stock?
Warren Buffet currently does not own shares in Protagonist Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
